Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) — Stock Price

Rs237.24 INR
▲ 3.87% today

Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) is currently trading at Rs237.24 INR, up 3.87% today. Over the past 52 weeks, shares have ranged between Rs88.15 and Rs246.44. This page tracks Ind-Swift Laboratories Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Ind-Swift Laboratories Limited market capitalisation.

Ind-Swift Laboratories Limited (INDSWFTLAB) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Ind-Swift Laboratories Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Ind-Swift Laboratories Limited Income Statement — Revenue, Profit & Earnings by Year

Ind-Swift Laboratories Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs5.62 Billion Rs12.81 Billion Rs12.07 Billion Rs10.39 Billion Rs8.91 Billion
Cost of Revenue Rs2.88 Billion Rs8.68 Billion Rs7.67 Billion Rs6.29 Billion Rs5.16 Billion
Gross Profit Rs2.74 Billion Rs4.13 Billion Rs4.40 Billion Rs4.10 Billion Rs3.75 Billion
Research & Development Rs23.05 Million Rs355.17 Million Rs425.74 Million Rs327.16 Million Rs330.13 Million
SG&A Rs1.19 Billion Rs367.83 Million Rs205.16 Million Rs204.06 Million Rs159.45 Million
Total Operating Expenses Rs3.18 Billion Rs2.12 Billion Rs2.59 Billion Rs3.17 Billion Rs2.64 Billion
Operating Income Rs-438.69 Million Rs2.01 Billion Rs1.82 Billion Rs924.23 Million Rs1.11 Billion
EBITDA Rs2.85 Billion Rs7.82 Billion Rs2.36 Billion Rs2.35 Billion Rs1.98 Billion
EBIT Rs2.61 Billion Rs7.02 Billion Rs1.79 Billion Rs1.04 Billion Rs1.11 Billion
Interest Expense Rs29.19 Million Rs511.04 Million Rs921.66 Million Rs955.46 Million Rs1.00 Billion
Income Before Tax Rs2.58 Billion Rs5.82 Billion Rs865.21 Million Rs125.32 Million Rs180.09 Million
Income Tax Expense Rs72.70 Million Rs1.60 Billion Rs386.90 Million Rs146.81 Million Rs211.56 Million
Net Income Rs2.50 Billion Rs4.21 Billion Rs475.97 Million Rs-21.49 Million Rs-31.47 Million

Ind-Swift Laboratories Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Ind-Swift Laboratories Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs14.38 Billion Rs14.60 Billion Rs18.24 Billion Rs18.01 Billion Rs18.18 Billion
Total Current Assets Rs8.65 Billion Rs9.59 Billion Rs11.65 Billion Rs10.75 Billion Rs9.44 Billion
Cash & Equivalents — Rs1.00K Rs1.00K — Rs-1.00K
Short-term Investments Rs393.66 Million Rs27.87 Million Rs49.54 Million Rs118.90 Million Rs83.02 Million
Net Receivables Rs1.65 Billion Rs1.69 Billion Rs5.31 Billion Rs4.95 Billion Rs4.81 Billion
Inventory Rs1.14 Billion Rs1.09 Billion Rs4.39 Billion Rs4.29 Billion Rs3.76 Billion
Property, Plant & Equipment Rs2.60 Billion Rs53.64 Million Rs5.93 Billion Rs6.37 Billion Rs7.48 Billion
Goodwill — — — Rs351.00K Rs2.11 Million
Total Liabilities Rs2.65 Billion Rs6.48 Billion Rs11.42 Billion Rs12.00 Billion Rs12.15 Billion
Total Current Liabilities Rs2.21 Billion Rs2.17 Billion Rs3.71 Billion Rs3.34 Billion Rs3.15 Billion
Long-term Debt Rs257.08 Million Rs111.63 Million Rs7.53 Billion Rs8.48 Billion Rs8.84 Billion
Net Debt Rs-3.87 Billion Rs-4.15 Billion Rs8.44 Billion Rs9.32 Billion Rs9.94 Billion
Total Stockholder Equity Rs11.73 Billion Rs9.36 Billion Rs6.82 Billion Rs6.01 Billion Rs6.04 Billion
Retained Earnings Rs-1.38 Billion Rs3.92 Billion Rs-293.31 Million Rs-780.50 Million Rs-762.42 Million

Ind-Swift Laboratories Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Ind-Swift Laboratories Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs-254.74 Million Rs-1.63 Billion Rs1.95 Billion Rs1.50 Billion Rs1.35 Billion
Capital Expenditures Rs644.06 Million Rs445.17 Million Rs127.71 Million Rs184.15 Million Rs43.97 Million
Free Cash Flow Rs-898.80 Million Rs-2.08 Billion Rs1.82 Billion Rs1.32 Billion Rs1.31 Billion
Investing Cash Flow Rs-1.10 Billion Rs-1.23 Billion Rs-133.68 Million Rs47.72 Million Rs-101.72 Million
Financing Cash Flow Rs692.05 Million Rs6.99 Billion Rs-1.86 Billion Rs-1.41 Billion Rs-1.24 Billion
Dividends Paid — — — — —
Stock-Based Compensation — — — — —
Depreciation Rs244.79 Million Rs533.03 Million Rs573.62 Million Rs1.31 Billion Rs872.92 Million
Change in Cash Rs-664.69 Million Rs4.13 Billion Rs-44.06 Million Rs141.69 Million Rs10.29 Million

Ind-Swift Laboratories Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Ind-Swift Laboratories Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 28, 2026 — — —
Feb 10, 2026 — — —
Nov 10, 2025 — — —
Aug 11, 2025 — — —
May 12, 2025 — — —
Feb 10, 2025 — — —
Nov 05, 2024 — — —